Navigation Links
High-Dose Vitamin B Risky for Diabetics With Kidney Disease
Date:4/27/2010

Study ties therapy to deteriorating renal function

TUESDAY, April 27 (HealthDay News) -- High-dose vitamin B therapy is dangerous for diabetics with kidney disease, and patients on this regimen should stop immediately, says a new study.

When the researchers began the study, they believed it would show that high-dose vitamin B therapy (folic acid, vitamin B6 and vitamin B12) would improve patients' kidney function and reduce their risk of heart attack and stroke.

But it turned out that patients on high-dose vitamin B therapy had significant worsening of kidney function, and twice as many heart and stroke incidents as patients taking a placebo.

"Because B vitamins are water soluble, we suspect that while healthy people would excrete excess vitamins in urine, those with renal failure would not be able to do so, perhaps causing the adverse effects we have seen in this study," Dr. David Spence, of the University of Western Ontario in Canada, said in a university news release.

"Vitamin B therapy may still be beneficial in people with normal kidney function, but this is clear evidence that high doses of vitamin B should not be given to those with kidney problems," he added.

The study is published in the April 28 issue of the Journal of the American Medical Association.

More than 40 percent of people with diabetes develop kidney disease.

More information

The National Kidney Foundation has more about diabetes and kidney disease.



-- Robert Preidt



SOURCE: University of Western Ontario, news release, April 27, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Instaflex Announces Partnership with GNC, the Nation's Leading Vitamin and Supplement Retailer
2. Better vitamin D status could mean better quality of life for seniors
3. Vitamin K may protect against developing non-Hodgkins lymphoma, say Mayo Clinic researchers
4. B-vitamins Help Protect Against Stroke, Heart Disease
5. Low vitamin D levels associated with more asthma symptoms and medication use
6. Vitamins C, E Wont Cut Risk of Pregnancy-Linked Hypertension
7. Minority Kids Lack Enough Vitamin D
8. SumNuts Vitamin Nuts Launched, Enhanced with Vitamin D3 and Calcium
9. Too Many Infants Short on Vitamin D
10. Study: Low Levels of Vitamin D Linked to Higher Rates of Asthma in African American Kids
11. Boosting Vitamin D Can Do a Heart Good
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... Rod Burkett, CEO of ... News website. , Rod has been at the forefront of Gardant since it was ... CEO, Rod has overseen the opening of more than 40 new senior living communities. ...
(Date:4/24/2017)... ... April 24, 2017 , ... Come to PAINWeekEnd (PWE) Tampa on May ... for an educational and exciting 2-day program. , An attendee at a recent ... they approach patients” about the course entitled Ain't Misbehavin': Decreasing and Managing Pain Patient ...
(Date:4/24/2017)... New York, NY (PRWEB) , ... April 24, ... ... students in 72 countries clearly shows that over the last decade, student well-being ... have ticked all the boxes of formal education, join the Islamic State to ...
(Date:4/24/2017)... ... 24, 2017 , ... “The Saint with Trin, and Omega Station”: a triple ... the creation of published author, Chris Jackson. Chris Jackson grew up in Abilene, ... Dallas Independent School District teaching English. He is heavily involved in the youth group ...
(Date:4/24/2017)... NC and Seattle, WA (PRWEB) , ... April ... ... utilized by 75+ leading lifestyle brands, work wear distributors and International relief organizations ... they can carry. The company also offers lifestyle and work wear collections via ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017 The Mobile X-Ray product segment ... healthy CAGR during the forecast period Mobile X-Ray ... global digital mobile X-Ray devices market, which is estimated to ... expanding at a CAGR of 7% over the forecast period. ... of more than US$ 100 Mn in 2017 over 2016. ...
(Date:4/19/2017)... April 19, 2017 Global Prostate Cancer ... on the prostate cancer therapeutics market analyzes the ... Increasing prevalence of prostate cancer, launch of promising ... development of new drugs & therapeutic biological products, ... due to lesser side effects are some of ...
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
Breaking Medicine Technology: